Top Biotechnology companies in Germany by Total Assets

This ranking features the top 18 Biotechnology companies in Germany ranked by Total Assets, totaling a Total Assets of USD 250.04 B, for June 29, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Germany has the highest Total Assets ?

The Biotechnology company in Germany with the highest Total Assets is Bayer AG (XETRA: BAYN.DE) at USD 114.78 B.
Which Biotechnology company in Germany has the lowest Total Assets ?

The Biotechnology company in Germany with the lowest Total Assets is Vivoryon Therapeutics N.V. (Amsterdam Stock Exchange: VVY.AS) at None.

What are the top 10 Biotechnology companies in Germany by Total Assets ?

The top 10 Biotechnology companies in Germany by Total Assets are Bayer AG, MERCK Kommanditgesellschaft auf Aktien, Siemens Healthineers AG, BioNTech SE, Evotec SE, Biotest AG, CureVac N.V., Formycon AG, Immatics N.V. and Stratec SE.
What are the bottom 10 Biotechnology companies in Germany by Total Assets ?

The bottom 10 Biotechnology companies in Germany by Total Assets are Vivoryon Therapeutics N.V., Anbio Biotechnology Class A Ordinary Shares, Mainz Biomed B.V., Heidelberg Pharma AG, BRAIN Biotech AG, Atai Life Sciences N.V., VITA 34 AG, Eckert & Ziegler Strahlen- und Medizintechnik AG, Stratec SE and Immatics N.V..